Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.

Yamamoto M, Miyagawa K, Hiura M, Taguchi M, Kihara Y, Abe S, Shimajiri S, Harada M.

Intern Med. 2012;51(7):727-32. Epub 2012 Apr 1.

2.

[A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].

Yoshida Y, Sugawara N, Minami T, Iwata N, Ikeda K, Endoh T, Sasano H.

Nihon Shokakibyo Gakkai Zasshi. 2013 Apr;110(4):660-8. Japanese.

PMID:
23558130
3.

[A case of large cell neuroendocrine carcinoma of the stomach with liver metastasis effectively treated with S-1 and CDDP combination therapy].

Fujimura Y, Nakahara O, Otao R, Goto H, Baba H.

Gan To Kagaku Ryoho. 2014 Mar;41(3):369-71. Japanese.

PMID:
24743286
4.

[Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].

Hachisuka H, Takahashi M, Kushima A, Nakamoto T, Takahashi K, Iwamura Y, Wakata M, Nagano K, Nakajima T, Nunomura M, Araki K.

Gan To Kagaku Ryoho. 2013 May;40(5):639-42. Japanese.

PMID:
23863590
5.

[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].

Nishimizu T, Minemura M, Kajiura S, Tokimitsu Y, Itaya Y, Yamawaki H, Kawai K, Tajiri K, Nakayama Y, Hosokawa A, Takahara T, Yasumura S, Shimizu S, Fukuoka J, Ishizawa S, Sawasaki T, Yanagisawa A, Sugiyama T.

Gan To Kagaku Ryoho. 2011 Feb;38(2):309-12. Japanese.

PMID:
21368502
6.

[Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].

Suda H, Omori K, Suematsu Y, Hiratsuka M, Takahashi M, Saito H, Ishibashi Y, Morita A, Wakabayashi K, Ito Y.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2388-90. Japanese.

PMID:
26805373
7.

S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer.

Kim MK, Lee KH, Jang BI, Kim TN, Eun JR, Bae SH, Ryoo HM, Lee SA, Hyun MS.

Jpn J Clin Oncol. 2009 Jan;39(1):49-53. doi: 10.1093/jjco/hyn126. Epub 2008 Dec 5.

PMID:
19060295
8.

A Rare Pancreatic Tumor That Underwent a Change in Morphology and Histopathologic Features During Chemotherapy.

Seino S, Tsuchiya A, Natsui M.

Gastroenterology. 2016 Feb;150(2):e11-3. doi: 10.1053/j.gastro.2015.06.049. Epub 2015 Dec 21. No abstract available.

PMID:
26718170
9.

[A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].

Hoshino H, Takeda Y, Nagano H, Nakamori S, Kobayashi S, Eguchi H, Marubashi S, Tanemura M, Kitagawa T, Umeshita K, Monden M, Doki Y, Mori M.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2419-21. Japanese.

PMID:
20037442
10.

A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.

Ueno H, Okusaka T, Ikeda M, Ishiguro Y, Morizane C, Matsubara J, Furuse J, Ishii H, Nagase M, Nakachi K.

Oncology. 2005;69(5):421-7. Epub 2005 Nov 25.

PMID:
16319514
11.

[A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].

Maeda T, Tsuchiya M, Ishii J, Koda T, Kubota Y, Katagiri T, Tamura A, Otsuka Y, Shibuya K, Kaneko H.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2184-6. Review. Japanese.

PMID:
25731464
12.

Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.

Yamauchi J, Kanai M, Matsumoto S, Nishimura T, Yazumi S, Kami K, Kawaguchi Y, Yasuda H, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Fukushima M, Doi R, Chiba T.

Pancreas. 2008 Apr;36(3):327-8. doi: 10.1097/MPA.0b013e31815cc464. No abstract available.

PMID:
18362852
13.
14.

[Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].

Matsumoto T, Takeji S, Asagi A, Kajiwara T, Nishina T, Hori S, Ikeda Y, Nadano S, Iguchi H.

Nihon Shokakibyo Gakkai Zasshi. 2011 Dec;108(12):2003-9. Japanese.

PMID:
22139487
15.

Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, Yokosuka O, Tanaka K, Moriyasu F, Nakamori S, Sato T.

Jpn J Clin Oncol. 2011 Aug;41(8):953-8. doi: 10.1093/jjco/hyr090. Epub 2011 Jun 29.

PMID:
21715364
16.

[Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].

Sato Y, Tsuchiya Y, Aizawa M, Nomura T, Nashimoto A.

Gan To Kagaku Ryoho. 2014 Sep;41(9):1151-4. Japanese.

PMID:
25248901
17.
18.

[A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].

Koga H, Miyoshi A, Nakamura J, Ide T, Kitahara K, Noshiro H.

Gan To Kagaku Ryoho. 2014 May;41(5):665-8. Review. Japanese.

PMID:
24917019
19.

[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].

Hatata T, Takaya S, Taniguchi K, Naka T, Kondo A, Ikeguchi M.

Gan To Kagaku Ryoho. 2011 Jan;38(1):109-12. Japanese.

PMID:
21368469
20.

[A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].

Kuji M, Yamamoto Y, Tani C, Kenno S, Kobayashi T.

Gan To Kagaku Ryoho. 2011 May;38(5):853-5. Japanese.

PMID:
21566453

Supplemental Content

Support Center